Next 10 |
home / stock / henky / henky news
2024-05-07 11:00:00 ET Major earnings expected before the bell on Wednesday include: Brookfield Asset Management ( BAM ) Emerson Electric ( EMR ) Shopify ( SHOP ) Teva Pharmaceutical Industries ( TEVA ) Uber Technologies ( UBER ) Read the fu...
2024-04-25 09:42:58 ET Summary Henkel reported full-year results for fiscal 2023 and while management was quite pleased about the results, they were rather mediocre in my opinion. Nevertheless, we see small signs of improvement and management is remaining optimistic about EPS grow...
2024-04-10 06:23:37 ET Summary H.B. Fuller's top line is under pressure due to a shaky manufacturing sector, despite falling material costs providing a boost to margins. The company's Q1 results showed weaker revenue, but gross margin outperformed expectations due to lower input c...
2024-03-05 11:28:51 ET More on Henkel AG Henkel AG & Co. KGaA 2023 Q4 - Results - Earnings Call Presentation Henkel AG & Co. KGaA Q4 2023 Earnings Call Transcript Henkel: Why It's Time To Sell The Preferred Shares Jeffries names Danone, Haleon and Hen...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
Henkel AG & Co. KGAA ADR (HENKY) is expected to report for Q4 2023
2024-02-14 15:18:58 ET Summary The preferred shares of Henkel AG & Co. KGaA are once again trading at a significant premium to the ordinary shares. In this update, I explain why I sold my position in HENOY/HENOF shares and why I believe that the market is - once again - acting...
2023-12-11 07:27:17 ET More on Danone and Henkel Haleon's Long-Term Growth Prospects Look Healthy On Solid Macro Trends Haleon: A Stable Pick The Investment Case For Haleon: Steady Shareholder Value Accumulation EU suggests label update to flag brain-related ...
2023-11-18 02:51:05 ET Summary Henkel's Q3 results showed a decline in revenue, but organic growth remained positive. Management raised guidance for organic sales growth and adjusted earnings per share for the full year. The business transformation and merger of the consumer b...
2023-11-09 09:15:01 ET Henkel AG & Co. KGaA (HENKY) Q3 2023 Earnings Conference Call November 09, 2023 03:00 AM ET Company Participants Leslie Iltgen - Head, Investor Relations Carsten Knobel - Chief Executive Officer Marco Swoboda - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
Henkel AG & Co KGAA ADR Repstg Ord Shs Company Name:
HENKY Stock Symbol:
OTCMKTS Market:
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
Henkel AG & Co. KGAA ADR (HENKY) is expected to report for Q4 2023
Despite the latest federal interest rate hikes, undervalued stocks with impressive financials are expected to deliver solid returns in the coming months. So, we think it could be wise to scoop up quality stocks Moderna (MRNA), Bayer (BAYRY), Henkel (HENKY), AGCO (AGCO), and Penske Automotive ...